Immunosuppressant-associated eruptions in pediatric inflammatory bowel disease: A case-control study

Research output: Contribution to journalArticlepeer-review

Abstract

Paradoxically, immunosuppressive therapy for inflammatory bowel disease (IBD) can induce psoriasiform or eczematous eruptions. This case-control study identified infliximab exposure, Crohn's disease, and history of inflammatory skin conditions as significant risk factors for these eruptions in children with IBD. Our results also showed possible trends in age and race.

Original languageEnglish
JournalPediatric Dermatology
DOIs
StateAccepted/In press - 2022

Keywords

  • adalimumab
  • Crohn's disease
  • eczema
  • immunosuppression
  • inflammatory bowel disease
  • infliximab
  • psoriasis

Fingerprint

Dive into the research topics of 'Immunosuppressant-associated eruptions in pediatric inflammatory bowel disease: A case-control study'. Together they form a unique fingerprint.

Cite this